Company / Current Assets per Share
Lipocine Inc. Current Assets per Share History
FY2013-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Assets per Share
$3.16
FY2025
5-year range
$0.39 / $4.37
FY2021-FY2025
Trend
-24.8%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Declined from $4.37 to $3.16 over the past 2 years.
Based on SEC 10-K filings.
3.16 in FY2025 with a 5-year CAGR of +36.2%.
Declined from $4.37 to $3.16 over the past 2 years.
Current Assets per Share over time
Growth rates
- 3-Year CAGR
- +101.3%
- 5-Year CAGR
- +36.2%
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, current assets per share decreased 24.8% year-over-year.
- Peak current assets per share was recorded in FY2013.
- Lowest current assets per share in the period was in FY2022.
Company context
Key Data Points
- Altman Z-Score -1.16 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current Assets per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $3.16 | -24.8% |
| FY2024 | $4.20 | -3.8% |
| FY2023 | $4.37 | +1029.6% |
| FY2022 | $0.39 | -41.6% |
| FY2021 | $0.66 | -1.6% |
| FY2020 | $0.67 | -25.5% |
| FY2019 | $0.90 | -7.7% |
| FY2018 | $0.98 | -90.5% |
| FY2013 | $10.33 | - |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026